Dimensional Fund Advisors LP Raises Stock Holdings in Kenvue Inc. $KVUE

Key Points

• Dimensional Fund Advisors LP increased its holdings in Kenvue Inc. by 4.9% during the first quarter, owning approximately 19.86 million shares valued at around $476.12 million.
• Kenvue's quarterly earnings report showed an Earnings Per Share (EPS) of $0.29, surpassing the consensus estimate of $0.28, despite a 4% drop in revenue year-over-year.
• The company recently increased its quarterly dividend from $0.21 to $0.2075, reflecting a 3.9% yield and a payout ratio of 112.16%.

Dimensional Fund Advisors LP lifted its stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 4.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 19,856,812 shares of the company's stock after buying an additional 932,633 shares during the period. Dimensional Fund Advisors LP owned approximately 1.03% of Kenvue worth $476,117,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the business. Horizon Investments LLC boosted its holdings in Kenvue by 5.5% in the 1st quarter. Horizon Investments LLC now owns 28,406 shares of the company's stock valued at $681,000 after purchasing an additional 1,489 shares during the last quarter. Providence Capital Advisors LLC lifted its stake in shares of Kenvue by 2.8% in the 1st quarter. Providence Capital Advisors LLC now owns 123,072 shares of the company's stock worth $2,951,000 after acquiring an additional 3,328 shares during the period. Trivium Point Advisory LLC acquired a new stake in shares of Kenvue in the first quarter valued at about $201,000. Vestmark Advisory Solutions Inc. raised its position in Kenvue by 119.5% during the first quarter. Vestmark Advisory Solutions Inc. now owns 21,946 shares of the company's stock worth $526,000 after acquiring an additional 11,950 shares during the last quarter. Finally, Neuberger Berman Group LLC lifted its holdings in Kenvue by 252.7% in the 1st quarter. Neuberger Berman Group LLC now owns 936,264 shares of the company's stock valued at $22,452,000 after purchasing an additional 670,791 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. UBS Group reduced their price target on shares of Kenvue from $25.00 to $23.00 and set a "neutral" rating on the stock in a research report on Thursday, July 17th. JPMorgan Chase & Co. cut their price objective on Kenvue from $27.00 to $26.00 and set an "overweight" rating for the company in a research report on Friday, July 25th. Citigroup dropped their target price on Kenvue from $24.50 to $22.00 and set a "neutral" rating on the stock in a report on Tuesday, July 15th. Canaccord Genuity Group dropped their price objective on Kenvue from $29.00 to $26.00 and set a "buy" rating on the stock in a report on Friday, August 8th. Finally, Bank of America reduced their price objective on Kenvue from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Tuesday, July 15th. Five analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $24.38.

Kenvue Price Performance

KVUE traded up $0.3850 on Tuesday, hitting $21.4850. 13,900,327 shares of the stock were exchanged, compared to its average volume of 17,538,854. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. The firm has a market capitalization of $41.23 billion, a price-to-earnings ratio of 29.03, a PEG ratio of 3.05 and a beta of 0.83. Kenvue Inc. has a 12 month low of $19.75 and a 12 month high of $25.17. The business has a 50-day moving average of $21.54 and a two-hundred day moving average of $22.42.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The firm's revenue was down 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Sell-side analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th will be issued a $0.2075 dividend. This is an increase from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Wednesday, August 13th. This represents a $0.83 annualized dividend and a yield of 3.9%. Kenvue's payout ratio is 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.